EU regulator says not to use heparin for COVID

On Monday The European Medicines Agency (EMA) passed instructions to doctors not to use the blood thinner heparin to treat rare blood clots and low blood platelets in people who got AstraZeneca’s (AZN.L) or Johnson & Johnson’s (JNJ.N) COVID-19 jabs.

Doctors across the world are under the process of investigating the possible causes of these clots and low platelets.

According to the ISTH guidelines, as and when a case of vaccine-caused clotting and low platelets is confirmed, doctors should continue only with non-heparin anticoagulants. Also, they should consider giving high-dose intravenous immunoglobulin, which is widely been recommended by doctors at Germany’s Greifswald University to help this rare condition.

Food and Drug Administration (FDA) and Centers for Disease Control have issued strong warnings against using heparin for such cases, as it is seen to make the condition worse.

Leave a Reply

Your email address will not be published. Required fields are marked *